Purple Biotech (NASDAQ:PPBT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Purple Biotech (PPBT) operate in?

Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Purple Biotech Stock (NASDAQ: PPBT) stock price, news, charts, stock research, profile.

Open	$0.38
Close	-
Volume / Avg.	38.10K / 356.14K
Day Range	0.37 - 0.40
52 Wk Range	0.30 - 1.80
Market Cap	$13.20M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	-
Days to Cover	1

Recent News

Why Purple Biotech (PPBT) Shares Are Trading Lower

Purple Biotech shares are trading lower by 11.5% during Monday's session. The company announced the exercise of warrants for $2 million gross proceeds.

Henry Khederian

Why Green Giant Shares Are Trading Lower By Around 37%; Here Are 20 Stocks Moving Premarket

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering. Green Giant shares dipped 37.1% to $0.1599 in pre-market trading. Here are some other stocks moving in pre-market trading.

Avi Kapoor

Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

Apr

May

Jul

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Purple Biotech Ltd

Sector

Health Care

Industry

Pharmaceuticals

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to over...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Purple Biotech (PPBT) stock?

You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.

View our list of the best stock brokerages

Who are Purple Biotech (PPBT) competitors?

Other companies in Purple Biotech’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).

What is the target price for Purple Biotech (PPBT) stock?

There is no analysis for Purple Biotech.

What is the forecast for Purple Biotech (PPBT) stock?

Purple Biotech has a consensus price target of $10.00.

Current stock price for Purple Biotech (PPBT)?

The stock price for Purple Biotech (NASDAQ: PPBT) is $0.3894 last updated Today at July 17, 2024 at 12:01 PM EDT.

Does Purple Biotech (PPBT) pay a dividend?

There are no upcoming dividends for Purple Biotech.

When is Purple Biotech (NASDAQ:PPBT) reporting earnings?

Purple Biotech’s Q2 earnings are confirmed for Tuesday, August 20, 2024.

Is Purple Biotech (PPBT) going to split?

There is no upcoming split for Purple Biotech.

What sector and industry does Purple Biotech (PPBT) operate in?

Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Purple Biotech

Purple Biotech (PPBT) Forecast